Patent · US Active

Pyridinamine-pyridone and pyrimidinamine- pyridone compounds

US11208423B2 · kind B2 · utility

2Cited by

0References

17Claims

0Family size

Assignee

Sprint Bioscience AB · SE

Inventors

Johan Lindström · Huddinge, SE
Rickard Forsblom · Tullinge, SE
Tobias Ginman · Tullinge, SE
Fredrik Rahm · Huddinge, SE
Jenny Viklund · Kungshättan, SE

Key dates

Filing date	Aug 23, 2018
Grant date	Dec 28, 2021
Priority date	—
Expiry date	Aug 23, 2038

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61K45/06
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The invention provides novel pyridinamine-pyridone and pyrimidinamine-pyridone compounds of formula (I), pharmaceutical compositions containing such compounds, and methods for using such compounds in treatment of diseases including cancer, type II diabetes, inflammatory disease, neurodegenerative disorders, cardiovascular disorders, autoimmune diseases and viral infections; (I) wherein R1, R2, R3 and Z are as defined in the specification.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.